We served as lead counsel for Envision Healthcare Corporation and current and former board members in four derivative actions asserting claims for breach of fiduciary duty, wasted corporate assets, unjust enrichment and violations of the Securities and Exchange Act of 1934 arising out of allegations of over billing and improperly billing medical patients, failing to supervise corporate action and failure to maintain proper internal controls. These cases were consolidated in 2018. Following a company merger, the case was dismissed in its entirety on October 25, 2018. Purrone v. Sanger et al., Case No. 3:17-cv-01472 (M.D. Tenn.).
Representation of Envision Healthcare Corporation in Derivative Actions
You Also May Be Interested In:
Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers
Pharos Capital’s Charter Health Care Group Acquires Physmed Home Health Care and Serene Care Hospice
Representation of Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of sister companies Physmed Home Health Care and Serene Care Hospice. Physmed Home Health specializes in geriatric care, delivering traditional home health nursing and therapy services, as well as social work and dietician services. Serene Care Hospice provides in-home end-of-life care with services including nursing care, spiritual care and bereavement support. Terms of the transaction were not disclosed.